Logo for Barinthus Biotherapeutics plc

Barinthus Biotherapeutics plc Investor Relations Material

Latest events

Logo for Barinthus Biotherapeutics plc

Status Update

Barinthus Biotherapeutics plc
Logo for Barinthus Biotherapeutics plc

Corporate Presentation

10 Jan, 2025
Logo for Barinthus Biotherapeutics plc

Q3 2024

5 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Barinthus Biotherapeutics plc

Access all reports
Barinthus Biotherapeutics plc is a biotechnology company focused on the development of novel immunotherapies for infectious diseases and cancer. The company specializes in T-cell activating therapeutics and next-generation vaccine platforms designed to enhance immune response. The company is headquartered in London, United Kingdom, and its shares are listed on the NASDAQ.